Kalender
Markeder
Råvarer
Valuta
Lagre
Obligationer
Krypto
Indikatorer
Lande
Kalender
Markeder
Valuta
Lagre
Råvarer
Obligationer
Krypto
Indtjening
Ferie
Lande
Usa
Forenede Kongerige
Euroområdet
Australien
Canada
Japan
Kina
Brasilien
Rusland
Indien
Mere Lande
Indikatorer
Rentesats
Inflation-Rate
Arbejdsløshed Rate
Bnp-Vækst
Bnp Per Capita
Betalingsbalance
Guldreserver
Statsgældsforvaltningen
Crude Oil Produktion
Benzin Priser
Kreditvurdering
Mere Indikatorer
Prognoser
Lande
Indikatorer
Valuta
Lagre
Råvarer
Obligationer
Krypto
Apps
App Store
Google Play
Twitter
Akebia Therapeutics | Ordinære Aktiekapital
Feedback
Ordinary Share Capital
Lave om
Dato
Acadia Pharmaceuticals
USD 16K
0
2023-12
Adcock Ingram Holdings
ZAR 15.28M
773K
2023-06
Agios Pharmaceuticals
USD 72K
0
2023-12
Alnylam Pharmaceuticals
USD 1.26M
4K
2023-12
Amgen
USD 32.75B
152M
2023-09
Ardelyx
USD 23K
1000
2023-09
AstraZeneca
USD 387M
0
2023-09
Avrobio
USD 4K
0
2023-09
Bayer
EUR 2.52B
0
2023-09
Celltrion
KRW 220.29B
73.89B
2023-12
Cspc Pharmaceutical
CNY 10.9B
0
2023-12
Ecofibre
AUD 116.54M
1M
2023-06
Exelixis
USD 311K
9K
2023-09
Fresenius Medical Care
EUR 293.41M
0
2022-12
GlaxoSmithKline
GBP 1.35B
0
2023-09
Ionis Pharmaceuticals
USD 144K
1000
2023-12
Ironwood Pharmaceuticals
USD 156K
0
2023-12
Kangmei Pharma
CNY 13.86B
0
2023-09
Knight Therapeutics
CAD 560.5M
11.43M
2023-09
Laboratorios Farma
EUR 3.24M
0
2023-06
Medical Developments International
AUD 105.73M
379K
2023-06
Moderna
USD 38.2K
100
2023-12
Neuren Pharmaceuticals
AUD 169.26M
1.52M
2023-06
Organigram Holdings
CAD 775.2M
5.22M
2023-03
Pharma Mar
EUR 11.01M
0
2023-09
Probiotec
AUD 53.18M
1.52M
2023-06
Qiagen NV
USD 2.7M
0
2023-09
Regeneron Pharmaceuticals
USD 102K
0
2023-09
Roche Holding
CHF 107M
0
2023-06
Sarepta Therapeutics
USD 9K
0
2023-09
Sartorius
EUR 68.4M
0
2023-09
Sino Biopharmaceutical
CNY 414.62M
284K
2023-06
Zz Pientze Pharmaceu
603.32M
0
2023-09
Akebia Therapeutics Ordinære Aktiekapital - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.